Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · IEX Real-Time Price · USD
4.500
+0.750 (20.00%)
Mar 28, 2024, 10:51 AM EDT - Market open

Summit Therapeutics Income Statement

Millions GBP. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2012
Revenue
00.711.810.86-57.0915.452.8800
Upgrade
Revenue Growth (YoY)
--61.03%110.35%--269.50%436.46%---
Upgrade
Gross Profit
00.711.810.86-57.0915.452.8800
Upgrade
Selling, General & Admin
30.2726.7423.6119.23-17.0114.9210.355.964.63
Upgrade
Research & Development
59.475285.3553.27-5236.2223.6921.0713.02
Upgrade
Other Operating Expenses
519.91-5.95-20.97-18.450-17.32-3.41-0.09-1.6-2.36
Upgrade
Operating Expenses
609.6572.798854.05-51.747.7433.9525.4315.29
Upgrade
Operating Income
-609.65-72.09-86.19-53.19-5.39-32.29-31.07-25.43-15.29
Upgrade
Interest Expense / Income
0000-01.481.083.60.62
Upgrade
Other Expense / Income
5.286.692.42-0.28--3.69-3.87-0.01-0.04-0.06
Upgrade
Pretax Income
-614.93-78.78-88.6-52.91-9.08-29.9-32.13-28.99-15.85
Upgrade
Income Tax
000-0.21--1.79-4.7-5.42-3.82-1.62
Upgrade
Net Income
-614.93-78.78-88.6-52.7-10.87-25.2-26.71-25.17-14.23
Upgrade
Shares Outstanding (Basic)
62019313270321712121212
Upgrade
Shares Outstanding (Diluted)
62019313270-17----
Upgrade
Shares Change
220.50%46.78%89.45%116.73%86.19%39.30%0.90%5.01%--
Upgrade
EPS (Basic)
-0.01-0.00-0.01-0.01-0.01-1.94-2.19-2.13-1.81
Upgrade
EPS (Diluted)
-0.01-0.00-0.01-0.01-0.01-1.94-2.19-2.13-1.81
Upgrade
Free Cash Flow
-76.66-42.21-72.89-48.53-26.25-35.26-18.6315.08-21.56-14.63
Upgrade
Free Cash Flow Per Share
-0.12-0.22-0.55-0.70-0.82-2.06-1.511.23-1.85-1.25
Upgrade
Gross Margin
-100.00%100.00%100.00%-100.00%100.00%100.00%--
Upgrade
Operating Margin
--10225.39%-4764.29%-6185.23%-9.44%-208.97%-1078.69%--
Upgrade
Profit Margin
--11174.75%-4897.84%-6127.56%-19.04%-163.09%-927.56%--
Upgrade
Free Cash Flow Margin
--5986.67%-4029.46%-5643.26%--61.77%-120.55%523.44%--
Upgrade
Effective Tax Rate
------19.66%----
Upgrade
EBITDA
-612.88-76.27-86.15-50.91-11.04-27.92-30.98-25.34-15.19
Upgrade
EBITDA Margin
--10818.16%-4762.13%-5919.42%-19.33%-180.69%-1075.82%--
Upgrade
Depreciation & Amortization
2.052.512.4622.131.950.50.070.060.04
Upgrade
EBIT
-614.93-78.78-88.6-52.91-9.08-28.42-31.06-25.4-15.23
Upgrade
EBIT Margin
--11174.75%-4897.84%-6152.33%-15.91%-183.92%-1078.34%--
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).